Aniruddha Ganguly Ph.D.

Program Director

Dr. Aniruddha Ganguly earned his Ph.D. in Cell Biology and trained in tumor biology. He has expertise in mechanisms of tumor development and metastasis, tumor microenvironment, tumor cell-macrophage interactions, biospecimen processing and banking, cancer biomarkers, clinical assay development, cancer diagnostics, molecular analysis technologies for cancer research, informatics technology for cancer research and cancer health disparities research. Before joining the National Cancer Institute (NCI) as a Program Director in 2011, Dr. Ganguly served as an Assistant Professor at Harvard Medical School/Harvard University for many years directing and conducting cancer biology research, and teaching MD/DMD students. During that time, his laboratory discovered a new protein-protein interaction between CEA and a 115 kDa monocyte/macrophage protein that has implications in colon tumorigenesis. He was supervisor of a CLIA certified IHC Clinical Services Laboratory of the department of Pathology at Massachusetts General Hospital, Boston. At the NCI, he has responsibilities for providing guidance to the planning, development, implementation, and evaluation of assigned biomedical research programs including, molecular diagnostic technologies, extracellular RNA/exosome initiative, brain tumor research, NCI's brain tumor clinical trials, evaluation of Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP) and core correlative science proposals. He organizes and hosts Cancer Diagnosis Program Science Session series. He has published many scholarly articles including book chapters, presented extensively and chaired scientific sessions in conferences both nationally and internationally, and received many awards including University gold-medal for academic excellence from India, Bharat Gaurav (Pride of India) award (2010) from India, excellence in teaching awards (2007 & 2011) from Harvard Medical School, Partners in Excellence Award from Massachusetts General Hospital/Partners HealthCare (2009) for outstanding performance and commitment to excellence, and NCI Director's Awards of Merit (2014 & 2015). He is founder and current President of the American Association of Indian Scientists in Cancer Research. He has a strong emphasis in mentoring and promoting young investigators involved in cancer research.